Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Haemophilia, Supplement
Haemophilia, Supplement is not currently indexed in Scopus. Published by Wiley-Blackwell Publishing Ltd.
Checked against the index lists dated .
ISSN 1355-0691Verify ISSN ↗
Publisher: Wiley-Blackwell Publishing Ltd
Cost to publish: About US$4,760 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Haemophilia, Supplement indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2004–2005).
What is the impact factor of Haemophilia, Supplement?
Haemophilia, Supplement has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
How much does it cost to publish in Haemophilia, Supplement?
The publisher lists an article processing charge of about US$4,760 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Haemophilia, Supplement and what is its ISSN?
Haemophilia, Supplement is published by Wiley-Blackwell Publishing Ltd. Its ISSN is 1355-0691.
Is Haemophilia, Supplement in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Haemophilia, Supplement open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Haemophilia, Supplement for 2 years, between 2004 and 2005. Coverage ended in 2005, 21 years ago, and Scopus now lists the title as inactive.
How well cited is Haemophilia, Supplement? — open metrics via OpenAlex
Haemophilia, Supplement has an h-index of 123 and a 2-year mean of 2.19 citations per paper (OpenAlex).
Haemophilia, Supplement published 226 papers in 2025; its busiest recent year was 2020 with 330. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Who publishes in Haemophilia, Supplement? — latest 99 articles, 2026
In its latest 99 research articles (2026), authors are most often from United States (11.6%), Japan (10.2%) and Italy (9.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Haemophilia, Supplement? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2005. 6 retracted papers are recorded (0.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2005
- Retracted papers 6 · 0.8 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Wiley-Blackwell Publishing Ltd
Wiley-Blackwell Publishing Ltd has 455 other titles in our data; 301 are currently indexed in Scopus.
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.